{"id":521254,"date":"2021-08-02T08:33:42","date_gmt":"2021-08-02T12:33:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/"},"modified":"2021-08-02T08:33:42","modified_gmt":"2021-08-02T12:33:42","slug":"phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/","title":{"rendered":"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI"},"content":{"rendered":"<div class=\"mw_release\">\n<p>FLORHAM PARK, N.J., Aug.  02, 2021  (GLOBE NEWSWIRE) &#8212; Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that Terrie Curran, Phathom\u2019s President and Chief Executive Officer, will participate in the \u201cInnovation in GI\u201d panel discussion at the BMO Biopharma Spotlight Series virtual conference on Thursday, August 12, 2021 at 10:50 a.m. ET.\u00a0\u00a0<\/p>\n<p>Company management will also participate in one-on-one meetings during the virtual conference.<\/p>\n<p>The on-demand webcast can be accessed under the News &amp; Events section of the Phathom website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=paDKHrT4tNLd8f_iBkQ6B1IPpWRwK5DhmVYwdlZryEltx5_Q4qb_qor3me13MB-AfQbU7SrWnGQbmEmdjhktfej1TUotjdZhJkGqcnf5IQ3GznWbVGxwH_LriOkZdncy4UzMwa8DOn0CLVHmQzq1pZKcMWSJ7kA7pkFxGcszYEe2jvBeKyoUG_r_6_nq1AnwnvdP2LmbxK6CoR1C3mvpZwALvayvlazakZgUdAoZaWI=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.phathompharma.com\/news-events\/events-and-presentations<\/a>. The recording will be available for 30 days following the event.<\/p>\n<p>\n        <strong>About Phathom Pharmaceuticals, Inc.<\/strong><br \/>\n        <br \/>Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HioRzhEld7uD-GM_3SjK02XkFV-iUUgqPArmH_zZ9yoUO7UDLHd8ODmoZgv1fQINY3n8H_hBDlcUy2J8Vr7Ejwei3AO9MC7ZPuZK-EP6Bw8=\" rel=\"nofollow noopener\" target=\"_blank\">www.phathompharma.com<\/a> or follow the Company on social media: LinkedIn at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r0mept9j5pYBYDkzS-QL8fk1H3A1M6JB7NcWfdLx56KzetfMuEm0BKalw4C77OzdcQwPLPSQTRfsn3XIaC8BNyUD4JrSZ3UI3uZpFKbJuKsURj1qBtzThYt4PWid4EtjFobGP12CXPj_4hEUY_UJPw==\" rel=\"nofollow noopener\" target=\"_blank\">www.linkedin.com\/company\/phathompharma<\/a> and Twitter <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kAjR9j6LyWl-ej5oWMuZPkykshrU11Kd-fmJxtMbngphWGCRkLt1-NS_Xp-kfzUXIHML_chk_DihMjJJTZEJLFtb7EepU73Nz1qoYmKkAiM=\" rel=\"nofollow noopener\" target=\"_blank\">@PhathomPharma<\/a>.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Nick Benedetto<br \/>1-877-742-8466<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9rxFreueK_E6X7o2lZh939l2jv1hLkteQ9GHM-l0159BfH7Q6K90V65HSOP82diyhskEfxoI-DXki17hB_Cda31F1BSvrHbcNgWK0wGJVXU=\" rel=\"nofollow noopener\" target=\"_blank\">media@phathompharma.com<\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Joe Hand<br \/>1-877-742-8466<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JAZ08w4I4kW8yADcRa0K98i2X4lMBXxsl4-9oHxafLXkfuOF23wZdktpFHDOxPDZ93ihMF-n2RMsT7fqH15Bfj-T-dDXvnT5WYVRAyDTEyM=\" rel=\"nofollow noopener\" target=\"_blank\">ir@phathompharma.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b41a2d31-f335-409d-8260-db828515d92b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FLORHAM PARK, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that Terrie Curran, Phathom\u2019s President and Chief Executive Officer, will participate in the \u201cInnovation in GI\u201d panel discussion at the BMO Biopharma Spotlight Series virtual conference on Thursday, August 12, 2021 at 10:50 a.m. ET.\u00a0\u00a0 Company management will also participate in one-on-one meetings during the virtual conference. The on-demand webcast can be accessed under the News &amp; Events section of the Phathom website at https:\/\/investors.phathompharma.com\/news-events\/events-and-presentations. The recording will be available for 30 days following the event. About Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals is a biopharmaceutical company focused on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-521254","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FLORHAM PARK, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that Terrie Curran, Phathom\u2019s President and Chief Executive Officer, will participate in the \u201cInnovation in GI\u201d panel discussion at the BMO Biopharma Spotlight Series virtual conference on Thursday, August 12, 2021 at 10:50 a.m. ET.\u00a0\u00a0 Company management will also participate in one-on-one meetings during the virtual conference. The on-demand webcast can be accessed under the News &amp; Events section of the Phathom website at https:\/\/investors.phathompharma.com\/news-events\/events-and-presentations. The recording will be available for 30 days following the event. About Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals is a biopharmaceutical company focused on the &hellip; Continue reading &quot;Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-02T12:33:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI\",\"datePublished\":\"2021-08-02T12:33:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/\"},\"wordCount\":229,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/\",\"name\":\"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=\",\"datePublished\":\"2021-08-02T12:33:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/","og_locale":"en_US","og_type":"article","og_title":"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI - Market Newsdesk","og_description":"FLORHAM PARK, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that Terrie Curran, Phathom\u2019s President and Chief Executive Officer, will participate in the \u201cInnovation in GI\u201d panel discussion at the BMO Biopharma Spotlight Series virtual conference on Thursday, August 12, 2021 at 10:50 a.m. ET.\u00a0\u00a0 Company management will also participate in one-on-one meetings during the virtual conference. The on-demand webcast can be accessed under the News &amp; Events section of the Phathom website at https:\/\/investors.phathompharma.com\/news-events\/events-and-presentations. The recording will be available for 30 days following the event. About Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals is a biopharmaceutical company focused on the &hellip; Continue reading \"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-02T12:33:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI","datePublished":"2021-08-02T12:33:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/"},"wordCount":229,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/","name":"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=","datePublished":"2021-08-02T12:33:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI5MDEzNyM0MzIzOTAzIzIxODk1NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phathom-pharmaceuticals-to-participate-in-the-bmo-biopharma-spotlight-series-innovation-in-gi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=521254"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521254\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=521254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=521254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=521254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}